Currently, there are 48.76M common shares owned by the public and among those 47.53M shares have been available to trade.
Insiders at the company have transacted a total of 38 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 13 of these insider trades were purchases, accounting for 84,047 shares. Insider sales of the common stock occurred on 25 occasions, with total insider shares sold totaling 81,575 shares.
However, the script later moved the day high at 94.44, down -0.33%. The company’s stock has a 5-day price change of -2.26% and -0.89% over the past three months. WK shares are trading -7.61% year to date (YTD), with the 12-month market performance up to 2.69% higher. It has a 12-month low price of $83.00 and touched a high of $116.00 over the same period. WK has an average intraday trading volume of 349.14K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -0.86%, -2.72%, and -4.59% respectively.
Institutional ownership of Workiva Inc (NYSE: WK) shares accounts for 87.48% of the company’s 48.76M shares outstanding.
It has a market capitalization of $5.07B and a beta (3y monthly) value of 1.06. The earnings-per-share (ttm) stands at -$2.54. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.92% over the week and 3.01% over the month.
Analysts forecast that Workiva Inc (WK) will achieve an EPS of $0.22 for the current quarter, $0.12 for the next quarter and $0.8 for 2024. The lowest estimate earnings-per-share for the quarter is $0.21 while analysts give the company a high EPS estimate of $0.23. Comparatively, EPS for the current quarter was $0.08 a year ago. Earnings per share for the fiscal year are expected to decrease by -83.90%, and 258.77% over the next financial year.
Looking at the support for the WK, a number of firms have released research notes about the stock. Wolfe Research stated their Outperform rating for the stock in a research note on August 28, 2023, with the firm’s price target at $120.
